Psoriatic arthritis trials in Australia

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

  Where

  Melbourne, Perth, Westmead

  Age

  1 year to 18 years

  People

  190 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT03773965
• Phase 3Taking people
  A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  Where

  Nedlands, South Brisbane, Westmead

  Age

  3 years to 64 years

  People

  196 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06663332 · EU 2023-509560-16-00
• Phase 3Taking people
  Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  Where

  Victoria Park

  Age

  18 years and over

  People

  1,182 worldwide

  Run by

  Takeda

  See details and how to joinNCT07286058 · EU 2025-522586-30-00
• Phase 3Taking people
  A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

  Where

  Clayton

  Age

  5 years to 17 years

  People

  40 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06100744 · EU 2023-506026-36-00
• Phase 1Taking people
  Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

  Where

  Birtinya, Charlestown

  Age

  18 years to 75 years

  People

  24

  Run by

  Seismic Therapeutic AU Pty Ltd

  See details and how to joinNCT07455578